BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 32803999)

  • 1. Characteristics and prognosis of pediatric myeloid sarcoma in the cytogenetic context of t(8;21).
    Hu G; Lu A; Wu J; Jia Y; Zuo Y; Ding M; Zhang L
    Pediatr Hematol Oncol; 2021 Feb; 38(1):14-24. PubMed ID: 32803999
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Prognostic value of dynamic monitoring of RUNX1-RUNX1T1 transcript in pediatric acute myeloid leukemia].
    Gao HT; Zhang Y; Sun K; Guo JM; Chen YQ; Chen XL; Shi J; Niu XN; Wang F; Huo L
    Zhonghua Xue Ye Xue Za Zhi; 2017 Mar; 38(3):210-215. PubMed ID: 28395444
    [No Abstract]   [Full Text] [Related]  

  • 3. Morphological characteristics, cytogenetic profile, and outcome of RUNX1-RUNX1T1-positive acute myeloid leukemia: Experience of an Indian tertiary care center.
    Gupta R; Yadav S; Parashar Y; Rahman K; Singh MK; Chandra D; Gupta A; Nityanand S
    Int J Lab Hematol; 2020 Feb; 42(1):37-45. PubMed ID: 31725954
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myeloid Sarcoma Predicts Superior Outcome in Pediatric AML; Can Cytogenetics Solve the Puzzle?
    Pramanik R; Tyagi A; Chopra A; Kumar A; Vishnubhatla S; Bakhshi S
    Clin Lymphoma Myeloma Leuk; 2018 Jun; 18(6):e249-e254. PubMed ID: 29680411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic Role of Postinduction Minimal Residual Disease and Myeloid Sarcoma Type Extramedullary Involvement in Pediatric RUNX1-RUNX1T1 (+) Acute Myeloid Leukemia.
    Lee JW; Kim S; Jang PS; Chung NG; Cho B; Im SA; Kim M
    J Pediatr Hematol Oncol; 2020 Apr; 42(3):e132-e139. PubMed ID: 31688618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloid sarcoma is associated with poor clinical outcome in pediatric patients with acute myeloid leukemia.
    Xu LH; Wang Y; Chen ZY; Fang JP
    J Cancer Res Clin Oncol; 2020 Apr; 146(4):1011-1020. PubMed ID: 31919567
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Allogeneic hematopoietic stem cell transplantation can improve the prognosis of high-risk pediatric t(8;21) acute myeloid leukemia in first remission based on MRD-guided treatment.
    Hu GH; Cheng YF; Lu AD; Wang Y; Zuo YX; Yan CH; Wu J; Sun YQ; Suo P; Chen YH; Chen H; Jia YP; Liu KY; Han W; Xu LP; Zhang LP; Huang XJ
    BMC Cancer; 2020 Jun; 20(1):553. PubMed ID: 32539815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic Impact of Extramedullary Infiltration in Pediatric Low-risk Acute Myeloid Leukemia: A Retrospective Single-center Study Over 10 Years.
    Hu GH; Lu AD; Jia YP; Zuo YX; Wu J; Zhang LP
    Clin Lymphoma Myeloma Leuk; 2020 Nov; 20(11):e813-e820. PubMed ID: 32680776
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pediatric myeloid sarcoma: a single institution clinicopathologic and molecular analysis.
    Zhou T; Bloomquist MS; Ferguson LS; Reuther J; Marcogliese AN; Elghetany MT; Roy A; Rao PH; Lopez-Terrada DH; Redell MS; Punia JN; Curry CV; Fisher KE
    Pediatr Hematol Oncol; 2020 Feb; 37(1):76-89. PubMed ID: 31682773
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CNS erythroblastic sarcoma: a potential emerging pediatric tumor type characterized by NFIA::RUNX1T1/3 fusions.
    Tauziède-Espariat A; Lew-Derivry L; Abbou S; Métais A; Pierron G; Reynaud S; Masliah-Planchon J; Mariet C; Hasty L; Dangouloff-Ros V; Boddaert N; Csanyi M; Aline-Fardin A; Lamaison C; Chrétien F; Beccaria K; Puget S; Varlet P
    Acta Neuropathol Commun; 2024 Jan; 12(1):12. PubMed ID: 38243303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The dynamics of RUNX1-RUNX1T1 transcript levels after allogeneic hematopoietic stem cell transplantation predict relapse in patients with t(8;21) acute myeloid leukemia.
    Qin YZ; Wang Y; Xu LP; Zhang XH; Chen H; Han W; Chen YH; Wang FR; Wang JZ; Chen Y; Mo XD; Zhao XS; Chang YJ; Liu KY; Huang XJ
    J Hematol Oncol; 2017 Feb; 10(1):44. PubMed ID: 28166825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical Characteristics and Treatment Outcomes of Myeloid Sarcoma in Children: The Experience of the Polish Pediatric Leukemia and Lymphoma Study Group.
    Samborska M; Barańska M; Wachowiak J; Skalska-Sadowska J; Thambyrajah S; Czogała M; Balwierz W; Kołtan S; Peszyńska-Żelazny K; Wysocki M; Ociepa T; Urasiński T; Wróbel G; Węcławek-Tompol J; Ukielska B; Chybicka A; Kitszel A; Krawczuk-Rybak M; Szmydki-Baran A; Malinowska I; Matysiak M; Mizia-Malarz A; Tomaszewska R; Szczepański T; Chodała-Grzywacz A; Karolczyk G; Maciejka-Kembłowska L; Irga-Jaworska N; Badowska W; Dopierała M; Kurzawa P; Derwich K
    Front Oncol; 2022; 12():935373. PubMed ID: 35875115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical and molecular characterization of myeloid sarcoma without medullary leukemia.
    Abbas HA; Reville PK; Geppner A; Rausch CR; Pemmaraju N; Ohanian M; Sasaki K; Borthakur G; Daver N; DiNardo C; Bueso-Ramos C; Pierce S; Jabbour E; Garcia-Manero G; Konopleva M; Ravandi F; Kantarjian H; Kadia TM
    Leuk Lymphoma; 2021 Dec; 62(14):3402-3410. PubMed ID: 34380367
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High aldehyde dehydrogenase activity at diagnosis predicts relapse in patients with t(8;21) acute myeloid leukemia.
    Yang L; Chen WM; Dao FT; Zhang YH; Wang YZ; Chang Y; Liu YR; Jiang Q; Zhang XH; Liu KY; Huang XJ; Qin YZ
    Cancer Med; 2019 Sep; 8(12):5459-5467. PubMed ID: 31364309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathological, Cytogenetic, and Prognostic Analysis of 131 Myeloid Sarcoma Patients.
    Kawamoto K; Miyoshi H; Yoshida N; Takizawa J; Sone H; Ohshima K
    Am J Surg Pathol; 2016 Nov; 40(11):1473-1483. PubMed ID: 27631510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Related Factors Affecting Long-term Prognosis of AML Children with Positive RUNX1-RUNX1T1].
    Teng GY; Qu WJ; Zhang K
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2019 Dec; 27(6):1767-1773. PubMed ID: 31839036
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics and prognostic factors of acute myeloid leukemia with t (8; 21) (q22; q22).
    Lai YY; Qiu JY; Jiang B; Lu XJ; Huang XJ; Zhang Y; Liu YR; Shi HL; Lu DP
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2005 Oct; 13(5):733-40. PubMed ID: 16277833
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low WT1 transcript levels at diagnosis predicted poor outcomes of acute myeloid leukemia patients with t(8;21) who received chemotherapy or allogeneic hematopoietic stem cell transplantation.
    Qin YZ; Wang Y; Zhu HH; Gale RP; Zhang MJ; Jiang Q; Jiang H; Xu LP; Chen H; Zhang XH; Liu YR; Lai YY; Jiang B; Liu KY; Huang XJ
    Chin J Cancer; 2016 May; 35():46. PubMed ID: 27197573
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical analysis of acute myeloid leukemia with t(8;21) (q22;q22) and loss of Y chromosome].
    Zhu CY; Yang H; Niu JH; Zhang Q; Xie XL; Wang LJ; Zhu HY; Yao ZL; Yu L; Jing Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Aug; 22(4):950-6. PubMed ID: 25130809
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical characteristics of pediatric patients with myeloid sarcoma without bone marrow involvement in Japan.
    Taga T; Imamura T; Nakashima K; Maeda N; Watanabe A; Miyajima Y; Sakaguchi S; Sano H; Hasegawa D; Kawasaki H; Adachi S; Takagi M; Koh K; Manabe A; Taki T; Ishida Y
    Int J Hematol; 2018 Oct; 108(4):438-442. PubMed ID: 29971602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.